American Diabetes Association

Last updated

American Diabetes Association
Founded1939;85 years ago (1939)
Type Nonprofit
13-1623888
PurposeDiabetes advocacy
Location
Website www.diabetes.org

The American Diabetes Association (ADA) is a United States-based nonprofit that seeks to educate the public about diabetes and to help those affected by it through funding research to manage, cure and prevent diabetes, including type 1 diabetes, type 2 diabetes, gestational diabetes, and pre-diabetes. It is a network of 565,000 volunteers which includes 20,000 healthcare professionals and administration staff members. [1]

Contents

History

The ADA was formally founded in 1939. [2] [3] It was founded by six physicians − including Dr. Herman O. Mosenthal, Dr. Joseph T. Beardwood Jr., Dr. Joseph H. Barach, and Dr. E. S. Dillion − at their annual meeting of the American College of Physicians. [4]

Each year the ADA hosts Scientific Sessions, a meeting for diabetes professionals. [5] The ADA has nearly 20,000 members.

In the early 2000s, the ADA struck a three-year, $1.5 million sponsorship deal with Cadbury-Schweppes, the world's largest confectioner products including Diet-Rite sodas, Snapple unsweetened tea and Mott's Apple Sauce.

According to a 2006 New York Times article, [6] "critics say the A.D.A. affiliation has helped the candy maker pose as a concerned corporate citizen, even as it supplies grocery stores with sugary and fattening foods like Dr Pepper and the Cadbury Creme Egg." The article goes on to say, "The A.D.A. began rethinking how it raises money from companies, especially from those whose primary business is selling foods and beverages that are high in calories, even if they have created some sugar free items. The group has allowed some food company deals to expire and has turned down millions of dollars in new sponsorships."

Accountability

The organization spends significant amounts on telemarketers including a contract with InfoCision, where telemarketers were instructed to lie to prospective donors that more of their donation was going toward the ADA than reality. [7] [8] [9]

The mostly highly compensated 20 individuals of the ADA received $5.3 million (an average of $266,000 each).

The Charity Navigator gave the ADA a 3-star overall rating, a 1-star financial rating and a 4-star accountability and transparency rating. [10]

Funded research

The ADA aims to give individuals with diabetes access to the care they need to optimize their health. [11] To work towards achieving this mission, the organization places effort into funding research projects that help minority groups navigate diabetes. [12] [13] The ADA works with various colleges, local governments, and companies to promote healthy lifestyles. [14] [15] They also fund research looking to control risk factors associated with diabetes, as seen in a recently published article discussing the role of microglia immune cells in diet-induced obesity. [16] 96% of ADA funded researchers remain dedicated to careers in diabetes science, every $1 the ADA invests in diabetes research leads to $12.47 in additional research funding.

Pay-to-play lawsuit

In 2023, Elizabeth Hanna, ex-chief nutritionist of the ADA, filed a whistleblower lawsuit claiming that the organisation accepted corporate money in exchange for recommending recipes that could harm people with diabetes. Hanna alleged that she was fired for refusing to endorse high amounts of Splenda in salads; ADA's scientific journal indicated that artificial sweeteners may raise the risk of type-2 diabetes. [17] [18]

See also

Notes

  1. "Who We Are | ADA". www.diabetes.org. Retrieved August 23, 2021.
  2. "Timeline". American Diabetes Association. Retrieved September 30, 2020.
  3. "American Diabetes Association". National Organization for Rare Diseases. Retrieved September 30, 2020.
  4. Striker, C (1956). Diabetes: Its Early Medical and Cultural History. New York, NY: Springer.
  5. "American Diabetes Association". professional.diabetes.org. Retrieved September 2, 2020.
  6. Santora, Marc (November 25, 2006). "In Diabetes Fight, Raising Cash and Keeping Trust". The New York Times. ISSN   0362-4331 . Retrieved September 2, 2020.
  7. "Charities Deceive Donors Unaware Money Goes to a Telemarketer". Bloomberg Markets . September 12, 2012. Archived from the original on March 5, 2013. Retrieved September 16, 2012.
  8. Deceptive Telemarketing Linked to Big Charities Chronicles of Philanthropy
  9. Myers L (September 12, 2012). "Donors unaware charity money goes to telemarketer". NBC Today Show. Archived from the original on January 28, 2013. Retrieved September 16, 2012.
  10. American Diabetes Association - Charity Navigator
  11. "Impact Statement". American Diabetes Association - Stop Diabetes. Retrieved November 5, 2018.
  12. Kaltman S, Serrano A, Talisman N, Magee MF, Cabassa LJ, Pulgar-Vidal O, Peraza D (February 2016). "Type 2 Diabetes and Depression: A Pilot Trial of an Integrated Self-management Intervention for Latino Immigrants". The Diabetes Educator. 42 (1): 87–95. doi:10.1177/0145721715617536. PMID   26590385. S2CID   3271552.
  13. Hasson RE, Adam TC, Pearson J, Davis JN, Spruijt-Metz D, Goran MI (2013). "Sociocultural and socioeconomic influences on type 2 diabetes risk in overweight/obese African-American and Latino-American children and adolescents". Journal of Obesity. 2013: 512914. doi: 10.1155/2013/512914 . PMC   3666294 . PMID   23762538.
  14. "American Diabetes Association Recognizes U.S. Companies and Organizations as New Health Champions". American Diabetes Association. July 21, 2016. Retrieved November 5, 2018.
  15. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B (December 2010). "Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement". Diabetes Care. 33 (12): e147–67. doi:10.2337/dc10-9990. PMC   2992225 . PMID   21115758.
  16. Valdearcos M, Douglass JD, Robblee MM, Dorfman MD, Stifler DR, Bennett ML, Gerritse I, Fasnacht R, Barres BA, Thaler JP, Koliwad SK (July 2017). "Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility". Cell Metabolism. 26 (1): 185–197.e3. doi:10.1016/j.cmet.2017.05.015. PMC   5569901 . PMID   28683286.
  17. Barsky, Neil (May 2, 2024). "Does the American Diabetes Association work for patients or companies? A lawsuit dared to ask". The Guardian. ISSN   0261-3077 . Retrieved May 7, 2024.
  18. "Ex-director accuses American Diabetes Association of 'pay to play' with sweetener Splenda". Reuters.

Related Research Articles

<span class="mw-page-title-main">Sucralose</span> Non-nutritive sweetener

Sucralose is an artificial sweetener and sugar substitute. As the majority of ingested sucralose is not metabolized by the body, it adds no calories. In the European Union, it is also known under the E number E955. It is produced by chlorination of sucrose, selectively replacing three of the hydroxy groups—in the C1 and C6 positions of the fructose portion and the C4 position of the glucose portion—to give a 1,6-dichloro-1,6-dideoxyfructose–4-chloro-4-deoxygalactose disaccharide. Sucralose is about 600 times sweeter than sucrose, three times as sweet as both aspartame and acesulfame potassium, and twice as sweet as sodium saccharin.

<span class="mw-page-title-main">Splenda</span> Brand of sugar substitute

Splenda is a global brand of sugar substitutes and reduced-calorie food products. While the company is known for its original formulation containing sucralose, it also manufactures items using natural sweeteners such as stevia, monk fruit and allulose. It is owned by the American company Heartland Food Products Group. The high-intensity sweetener ingredient sucralose used in Splenda Original is manufactured by the British company Tate & Lyle.

<span class="mw-page-title-main">Obesity</span> Medical condition in which excess body fat harms health

Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it can potentially have negative effects on health. People are classified as obese when their body mass index (BMI)—a person's weight divided by the square of the person's height—is over 30 kg/m2; the range 25–30 kg/m2 is defined as overweight. Some East Asian countries use lower values to calculate obesity. Obesity is a major cause of disability and is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis.

<span class="mw-page-title-main">Sugar substitute</span> Sugarless food additive intended to provide a sweet taste

A sugar substitute is a food additive that provides a sweetness like that of sugar while containing significantly less food energy than sugar-based sweeteners, making it a zero-calorie or low-calorie sweetener. Artificial sweeteners may be derived through manufacturing of plant extracts or processed by chemical synthesis. Sugar substitute products are commercially available in various forms, such as small pills, powders, and packets.

<span class="mw-page-title-main">Type 2 diabetes</span> Type of diabetes mellitus with high blood sugar and insulin resistance

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Symptoms may also include increased hunger, having a sensation of pins and needles, and sores (wounds) that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

<span class="mw-page-title-main">Low-carbohydrate diet</span> Diets restricting carbohydrate consumption

Low-carbohydrate diets restrict carbohydrate consumption relative to the average diet. Foods high in carbohydrates are limited, and replaced with foods containing a higher percentage of fat and protein, as well as low carbohydrate foods.

<span class="mw-page-title-main">American Heart Association</span> American non-profit health organization

The American Heart Association (AHA) is a nonprofit organization in the United States that funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. They are known for publishing guidelines on cardiovascular disease and prevention, standards on basic life support, advanced cardiac life support (ACLS), pediatric advanced life support (PALS), and in 2014 issued the first guidelines for preventing strokes in women. The American Heart Association is also known for operating a number of highly visible public service campaigns starting in the 1970s, and also operates several fundraising events.

<span class="mw-page-title-main">Diet soda</span> Type of sugar-free or artificially sweetened soda

Diet or light beverages are generally sugar-free, artificially sweetened beverages with few or no calories. They are marketed for diabetics and other people who want to reduce their sugar and/or caloric intake.

<span class="mw-page-title-main">Healthy diet</span> Type of diet

A healthy diet is a diet that maintains or improves overall health. A healthy diet provides the body with essential nutrition: fluid, macronutrients such as protein, micronutrients such as vitamins, and adequate fibre and food energy.

<span class="mw-page-title-main">Hyperinsulinemia</span> Abnormal increase in insulin in the bloodstream relative to glucose

Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. While it is often mistaken for diabetes or hyperglycaemia, hyperinsulinemia can result from a variety of metabolic diseases and conditions, as well as non-nutritive sugars in the diet. While hyperinsulinemia is often seen in people with early stage type 2 diabetes mellitus, it is not the cause of the condition and is only one symptom of the disease. Type 1 diabetes only occurs when pancreatic beta-cell function is impaired. Hyperinsulinemia can be seen in a variety of conditions including diabetes mellitus type 2, in neonates and in drug-induced hyperinsulinemia. It can also occur in congenital hyperinsulinism, including nesidioblastosis.

A chronic condition is a health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include diabetes, functional gastrointestinal disorder, eczema, arthritis, asthma, chronic obstructive pulmonary disease, autoimmune diseases, genetic disorders and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin for diabetics and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.

A diabetic diet is a diet that is used by people with diabetes mellitus or high blood sugar to minimize symptoms and dangerous complications of long-term elevations in blood sugar.

<span class="mw-page-title-main">Prediabetes</span> Predisease state of hyperglycemia with high risk for diabetes

Prediabetes is a component of metabolic syndrome and is characterized by elevated blood sugar levels that fall below the threshold to diagnose diabetes mellitus. It usually does not cause symptoms but people with prediabetes often have obesity, dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. It is also associated with increased risk for cardiovascular disease (CVD). Prediabetes is more accurately considered an early stage of diabetes as health complications associated with type 2 diabetes often occur before the diagnosis of diabetes.

Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1 that is released by the gut after eating.

Funding bias, also known as sponsorship bias, funding outcome bias, funding publication bias, and funding effect, refers to the tendency of a scientific study to support the interests of the study's financial sponsor. This phenomenon is recognized sufficiently that researchers undertake studies to examine bias in past published studies. Funding bias has been associated, in particular, with research into chemical toxicity, tobacco, and pharmaceutical drugs. It is an instance of experimenter's bias.

<span class="mw-page-title-main">Added sugar</span> Caloric sweeteners added to food and beverages

Added sugars or free sugars are sugar carbohydrates added to food and beverages at some point before their consumption. These include added carbohydrates, and more broadly, sugars naturally present in honey, syrup, fruit juices and fruit juice concentrates. They can take multiple chemical forms, including sucrose, glucose (dextrose), and fructose.

<span class="mw-page-title-main">Sweetened beverage</span> Type of beverage

Sugar-sweetened beverages (SSB) are any beverage with added sugar. They have been described as "liquid candy". Consumption of sugar-sweetened beverages have been linked to weight gain and an increased risk of cardiovascular disease mortality. According to the CDC, consumption of sweetened beverages is also associated with unhealthy behaviors like smoking, not getting enough sleep and exercise, and eating fast food often and not enough fruits regularly.

<span class="mw-page-title-main">Diabetes</span> Group of endocrine diseases characterized by high blood sugar levels

Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves. Untreated or poorly treated diabetes accounts for approximately 1.5 million deaths every year.

Outreach Calling Inc is a for-profit fundraiser which was incorporated in 2009. It is headquartered in New Jersey and has offices in the United States and Canada with a virtual office in Reno, Nevada. The firm's telemarketers solicit funds on behalf of not-for-profit charities.

<span class="mw-page-title-main">Madras Diabetes Research Foundation</span> Nonprofit organization in Chennai, India

The Madras Diabetes Research Foundation (MDRF) is a medical research organization located in Gopalapuram, Chennai. MDRF was established in 1996 by an eminent diabetologist, Dr. V. Mohan.